[PMID: 36707132] PubMed record related to this compound for laboratory literature review
FDA review: Standard 10-month review period after NDA acceptance
This is not a personal recommendation
The program includes physician-managed GLP-1 weight loss (semaglutide and tirzepatide), bioidentical hormone replacement therapy via pellet insertion for women and men, NAD+ infusions for cellular health and recovery, and B12/lipotropic injection blends for energy and metabolism support
Always discuss any supplementincluding vitamins, minerals, herbs, or weight loss aidswith your PlexusDx provider before starting
However, many have absorption issues, while injections carry their own danger